Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.

Agrawal M, Emanuel E, Richards B, Richards W, Roddy K, Thambi P

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (11)

    1. Caution before canonisation: a clinical and implementation science perspective on psychedelics 2026-10-05 · Expand citations
    2. Study participant perceptions of the relevance of therapist and study team personal psychedelic experience 2026-10-03 · Expand citations
    3. Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis 2026-07-20 · Expand citations
    4. Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview 2026-07-13 · Expand citations
    5. Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico 2026-06-17 · Expand citations
    6. Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration 2026-04-10 · Expand citations
    7. Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
    8. Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study 2026-02-12 · Expand citations
    9. Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study 2026-01-18 · Expand citations
    10. Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder 2025-09-04 · Expand citations
    11. Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer) 2022-10-03 · Expand citations